Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Sci Rep ; 8(1): 13215, 2018 09 04.
Article in English | MEDLINE | ID: mdl-30181651

ABSTRACT

Rotavirus and noroviruses are major causes of diarrhea. Variable rotavirus vaccination efficacy in Africa and Asia is multifactorial, including the diversity of circulating strains and viral co-infection. We describe a multiplexed assay that detects and genotypes viruses from stool specimens. It includes a one-step reverse transcriptase PCR reaction, a ligase detection reaction (LDR), then hybridization of fluorescent products to micro-beads. In clinical samples it detects rotavirus, caliciviruses (sapovirus and norovirus), mixed infections, and genotypes or genogroups of rotaviruses and noroviruses, respectively. The assay also has the capacity to detect hepatitis A. The assay was validated on reference isolates and 296 stool specimens from the US and Ghana. The assay was 97% sensitive and 100% specific. The genogroup was concordant in 100% of norovirus, and the genotype in 91% and 89% of rotavirus G- and P-types, respectively. Two rare rotavirus strains, G6P[6] and G6P[8], were detected in stool specimens from Ghana. The high-throughput assay is sensitive, specific, and may be of utility in the epidemiological surveillance for rare and emerging viral strains post-rotavirus vaccine implementation.


Subject(s)
Diarrhea/virology , Feces/virology , Norovirus/genetics , Rotavirus/classification , Rotavirus/genetics , Caliciviridae Infections/diagnosis , Caliciviridae Infections/epidemiology , Caliciviridae Infections/virology , Child , Diarrhea/diagnosis , Diarrhea/epidemiology , Genotyping Techniques , Ghana/epidemiology , Humans , Multiplex Polymerase Chain Reaction , Norovirus/isolation & purification , Phylogeny , Rotavirus/isolation & purification , Rotavirus Infections/diagnosis , Rotavirus Infections/epidemiology , Rotavirus Infections/virology , Sapovirus/genetics , Sapovirus/isolation & purification
2.
PLoS One ; 10(9): e0138484, 2015.
Article in English | MEDLINE | ID: mdl-26381398

ABSTRACT

CDC designated category A infectious agents pose a major risk to national security and require special action for public health preparedness. They include viruses that cause viral hemorrhagic fever (VHF) syndrome as well as variola virus, the agent of smallpox. VHF is characterized by hemorrhage and fever with multi-organ failure leading to high morbidity and mortality. Smallpox, a prior scourge, has been eradicated for decades, making it a particularly serious threat if released nefariously in the essentially non-immune world population. Early detection of the causative agents, and the ability to distinguish them from other pathogens, is essential to contain outbreaks, implement proper control measures, and prevent morbidity and mortality. We have developed a multiplex detection assay that uses several species-specific PCR primers to generate amplicons from multiple pathogens; these are then targeted in a ligase detection reaction (LDR). The resultant fluorescently-labeled ligation products are detected on a universal array enabling simultaneous identification of the pathogens. The assay was evaluated on 32 different isolates associated with VHF (ebolavirus, marburgvirus, Crimean Congo hemorrhagic fever virus, Lassa fever virus, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia virus (the agent of smallpox and its vaccine strain, respectively). The assay was able to detect all viruses tested, including 8 sequences representative of different variola virus strains from the CDC repository. It does not cross react with other emerging zoonoses such as monkeypox virus or cowpox virus, or six flaviviruses tested (St. Louis encephalitis virus, Murray Valley encephalitis virus, Powassan virus, Tick-borne encephalitis virus, West Nile virus and Japanese encephalitis virus).


Subject(s)
Hemorrhagic Fevers, Viral/diagnosis , Multiplex Polymerase Chain Reaction/methods , Smallpox/diagnosis , Variola virus/isolation & purification , Viruses/isolation & purification , Hemorrhagic Fevers, Viral/virology , Humans , Smallpox/virology
3.
Diagn Microbiol Infect Dis ; 79(2): 135-40, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24709368

ABSTRACT

Enteric pathogens that cause gastroenteritis remain a major global health concern. The goal of this study was to develop a multiplex PCR/ligation detection reaction (LDR) assay for the detection of all NIAID category B bacterial food and water-borne pathogens directly from stool specimens. To validate the PCR/LDR assay, clinical isolates of Campylobacter spp., Vibrio spp., Shigella spp., Salmonella spp., Listeria monocytogenes, Yersinia enterocolitica, and diarrheagenic Escherichia coli were tested. The sensitivity and specificity of the assay were assessed using a large number of seeded culture-negative stool specimens and a smaller set of clinical specimens from Haiti. The overall sensitivity ranged from 91% to 100% (median 100%) depending on the species. For the majority of organisms, the sensitivity was 100%. The overall specificity based on initial testing ranged from 98% to 100% depending on the species. After additional testing of discordant samples, the lowest specificity was 99.4%. PCR/LDR detected additional category B agents (particularly diarrheagenic E. coli) in 11/40 specimens from Haiti that were culture-positive for V. cholerae and in approximately 1% of routine culture-negative stool specimens from a hospital in New York. This study demonstrated the ability of the PCR/LDR assay to detect a large comprehensive panel of category B enteric bacterial pathogens as well as mixed infections. This type of assay has the potential to provide earlier warnings of possible public health threats and more accurate surveillance of food and water-borne pathogens.


Subject(s)
Bacteria/isolation & purification , Bacteriological Techniques/methods , Feces/microbiology , Foodborne Diseases/diagnosis , Gastroenteritis/diagnosis , Molecular Diagnostic Techniques/methods , Multiplex Polymerase Chain Reaction/methods , Bacteria/classification , Foodborne Diseases/microbiology , Gastroenteritis/microbiology , Guidelines as Topic , National Institute of Allergy and Infectious Diseases (U.S.) , Sensitivity and Specificity , United States
4.
PLoS One ; 6(12): e28566, 2011.
Article in English | MEDLINE | ID: mdl-22180786

ABSTRACT

BACKGROUND: Acinetobacter baumannii is an increasingly multidrug-resistant (MDR) cause of hospital-acquired infections, often associated with limited therapeutic options. We investigated A. baumannii isolates at a New York hospital to characterize genetic relatedness. METHODS: Thirty A. baumannii isolates from geographically-dispersed nursing units within the hospital were studied. Isolate relatedness was assessed by repetitive sequence polymerase chain reaction (rep-PCR). The presence and characteristics of integrons were assessed by PCR. Metabolomic profiles of a subset of a prevalent strain isolates and sporadic isolates were characterized and compared. RESULTS: We detected a hospital-wide group of closely related carbapenem resistant MDR A. baumannii isolates. Compared with sporadic isolates, the prevalent strain isolates were more likely to be MDR (p = 0.001). Isolates from the prevalent strain carried a novel Class I integron sequence. Metabolomic profiles of selected prevalent strain isolates and sporadic isolates were similar. CONCLUSION: The A. baumannii population at our hospital represents a prevalent strain of related MDR isolates that contain a novel integron cassette. Prevalent strain and sporadic isolates did not segregate by metabolomic profiles. Further study of environmental, host, and bacterial factors associated with the persistence of prevalent endemic A. baumannii strains is needed to develop effective prevention strategies.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter Infections/microbiology , Acinetobacter baumannii/pathogenicity , Endemic Diseases , Hospitals , Acinetobacter Infections/drug therapy , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/genetics , Acinetobacter baumannii/metabolism , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Humans , Integrons/genetics , Metabolome , Molecular Epidemiology , New York City/epidemiology
5.
J Clin Microbiol ; 48(5): 1924-5, 2010 May.
Article in English | MEDLINE | ID: mdl-20220162

ABSTRACT

Clinical specimens cultured on two selective fungal media, inhibitory mold agar (IMA) and Sabouraud dextrose agar (SDA), were compared with respect to recovery of fungi. Of the 840 fungal isolates recovered, 69.3% grew on both IMA and SDA; 24.9% grew only on IMA; and 5.8% grew only on SDA, showing that IMA is superior (P=0.003).


Subject(s)
Culture Media/chemistry , Fungi/growth & development , Fungi/isolation & purification , Mycology/methods , Agar , Glucose/metabolism , Humans , Mycoses/diagnosis , Sensitivity and Specificity
6.
Diagn Microbiol Infect Dis ; 64(2): 233-5, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19345034

ABSTRACT

Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae may appear susceptible to imipenem or meropenem by routine susceptibility testing. We report a series of patients with infections caused by K. pneumoniae isolates, which yielded imipenem-susceptible results but were subsequently KPC-positive by polymerase chain reaction. When these infections were treated with imipenem or meropenem, frequent clinical and microbiologic failures were observed.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Proteins/biosynthesis , Imipenem/therapeutic use , Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , Thienamycins/therapeutic use , beta-Lactamases/biosynthesis , Adult , Aged , Aged, 80 and over , Bacterial Proteins/genetics , Female , Genes, Bacterial , Humans , Infant , Klebsiella pneumoniae/isolation & purification , Male , Meropenem , Middle Aged , Polymerase Chain Reaction , Treatment Failure , Treatment Outcome , Young Adult , beta-Lactamases/genetics
7.
J Clin Microbiol ; 45(4): 1087-92, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17267631

ABSTRACT

The performance of the new VITEK 2 Advanced Colorimetry yeast identification (YST) card for use with the VITEK 2 system (bioMérieux, Inc., Hazelwood, MO) was compared to that of the API 20C AUX (API) system (bioMérieux SA, Marcy-l'Etoile, France) in a multicenter evaluation. A total of 12 quality control, 64 challenge, and 623 clinical yeast isolates were used in the study. Comparisons of species identification, platform reliability, and substrate reproducibility were made between YST and API, with API considered the reference standard. Quality control testing to assess system and substrate reproducibility matched expected results >/=95% of the time. The YST card correctly identified 100% of the challenge strains, which covered the species range of the manufacturer's performance claims. Using clinical isolates, the YST card correctly identified 98.5%, with 1.0% of isolates incorrectly identified and 0.5% unidentified. Among clinical isolates, the YST card generated fewer low-discrimination results (18.9%) than did API (30.0%). The time to identification with YST was 18 h, compared to 48 to 72 h with API. The colorimetric YST card used with the VITEK 2 provides a highly automated, objective yeast identification method with excellent performance and reproducibility. We found this system useful for timely and accurate identification of significant yeast species in the clinical microbiology laboratory.


Subject(s)
Colorimetry/methods , Mycological Typing Techniques/methods , Mycoses/microbiology , Yeasts/classification , Humans , Mycoses/diagnosis , Quality Control , Reference Standards , Reproducibility of Results , Sensitivity and Specificity , Time Factors , Yeasts/isolation & purification
9.
Surg Infect (Larchmt) ; 6(1): 41-54, 2005.
Article in English | MEDLINE | ID: mdl-15865550

ABSTRACT

BACKGROUND: Conceptually, appropriateness of antibiotic therapy includes choice of agent relative to susceptibility of pathogens as well as dosing, timing of onset, and duration of therapy, but is most commonly considered in terms of choice of antibiotic. It has been suggested that inappropriate antibiotic selection can result in increased mortality. This study was performed to elucidate the role of scheduled, rotating antibiotic therapy in defining mortality among febrile, infected surgical ICU patients. METHODS: Prospective inception-cohort study of 356 patients during their initial episode of fever (temperature > 38.2 degrees C), caused by infection diagnosed by positive cultures or direct inspection (some cases of peritonitis). Collected data included age, gender, admission APACHE III score, peak temperature, microbial isolates and susceptibility, source of infection, multiple organ dysfunction score, mortality, and several time intervals (time that cultures were collected, time from collection to antibiotic prescription, time from collection to antibiotic administration, duration of therapy). RESULTS: The mean age was 63 +/- 1 years, the mean APACHE III score was 74 +/- 2 points, the mean multiple organ dysfunction score was 8 +/- 1 points, and overall mortality was 31%. Neither the source of infection nor the specific isolate influenced mortality. Antibiotic therapy was appropriate (covered the isolates) in 94% of cases, and did not influence mortality. Duration of therapy was identical between groups (5.1 +/- 0.3 vs. 5.4 +/- 0.3 days, p = 0.61). By logistic regression (dependent variable = mortality), APACHE III score OR 1.025, 95% C.I. 1.021-1.04) and delayed antibiotic administration (30-min intervals, OR 1.021, 95% C.I. 1.003-1.038) were independent predictors of mortality. CONCLUSIONS: The use of scheduled monthly antibiotic cycling in the surgical ICU is associated with a high rate of "appropriate" antibiotic therapy, and appears to maintain or improve resistance patterns. Because antibiotic therapy was mostly appropriate for isolates, initial inappropriate therapy could not be identified as a risk factor for mortality. However, in the setting of appropriate antibiotic choice, the prompt initial administration of antibiotics appears to be crucial for survival, but neither site of infection nor specific pathogen are influential.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Surgical Wound Infection/drug therapy , Surgical Wound Infection/mortality , APACHE , Anti-Bacterial Agents/administration & dosage , Cohort Studies , Critical Illness , Drug Administration Schedule , Hospital Mortality , Humans , Length of Stay , Logistic Models , Middle Aged , Prospective Studies , Surgical Wound Infection/microbiology , Survival Rate , Time Factors
10.
Infect Immun ; 73(5): 2958-66, 2005 May.
Article in English | MEDLINE | ID: mdl-15845502

ABSTRACT

SoxR is a transcriptional regulator that controls an oxidative stress response in Escherichia coli. The regulator is primarily activated by superoxide anion-dependent oxidation. Activated SoxR turns on transcription of a single gene, soxS, which encodes a transcriptional regulator that activates a regulon that includes dozens of oxidative stress response genes. SoxR homologues have been identified in many bacterial species, including the opportunistic pathogen Pseudomonas aeruginosa. However, the expected SoxR partner, SoxS, has not been found in P. aeruginosa. Thus, the primary gene target(s) of P. aeruginosa SoxR is unknown and the involvement of this regulator in the oxidative stress response of the bacterium remains unclear. We utilized transcriptome profiling to identify the P. aeruginosa SoxR regulon and constructed and characterized an unmarked P. aeruginosa DeltasoxR mutant. We provide evidence indicating that P. aeruginosa SoxR activates a six-gene regulon in response to O(2)(.-)-induced stress. The regulon includes three transcriptional units: (i) the recently identified mexGHI-ompD four-gene operon, which encodes a multidrug efflux pump system involved in quorum-sensing signal homeostasis; (ii) gene PA3718, encoding a probable efflux pump; and (iii) gene PA2274, encoding a probable monooxygenase. We also demonstrate that P. aeruginosa SoxR is not a key regulatory player in the oxidative stress response. Finally, we show that P. aeruginosa SoxR is required for virulence in a mouse model of intrapulmonary infection. These results demonstrate that the E. coli-based SoxRS paradigm does not hold in P. aeruginosa and foster new hypotheses for the possible physiological role of P. aeruginosa SoxR.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Oxidative Stress , Pseudomonas aeruginosa/pathogenicity , Transcription Factors/metabolism , Animals , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Base Sequence , Heat-Shock Response , Lung Diseases/microbiology , Lung Diseases/mortality , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Oligonucleotide Array Sequence Analysis , Proteome , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/metabolism , Pseudomonas aeruginosa/physiology , Transcription Factors/chemistry , Transcription Factors/genetics , Transcription, Genetic , Virulence
11.
J Clin Microbiol ; 43(3): 1210-2, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15750085

ABSTRACT

The chromogenic medium BBL CHROMagar Candida (CAC) was evaluated as a sole primary medium for the isolation of yeasts from clinical specimens in which yeasts are the primary concern. Additionally, the reliability of the rapid-assimilation-of-trehalose (RAT) test in yielding correct results with isolates taken from CAC was assessed. A total of 270 throat, urine, and genital (TUG) specimens were streaked onto CAC, Sabouraud dextrose agar (SDA), inhibitory mold agar (IMA), and Mycosel (MYC). A total of 69 blood culture broths that were smear positive for yeast were streaked onto CAC and SDA. A 1-h RAT test (NCCLS M35-A) was performed simultaneously on isolates from CAC and SDA. A total of 112 TUG specimens yielded yeast colonies (CAC, 111 colonies; IMA, 105; SDA, 103; MYC, 91). The 69 blood culture yeasts grew on both CAC and SDA. Mixed cultures of yeasts were detected on 11 CAC plates but were unrecognized on other media. Colonies suspected of being C. glabrata on 32 CAC plates were all RAT test positive and confirmed to be C. glabrata; of 59 colonies with various characteristics of color and morphology on CAC, none were RAT positive, and all were conventionally identified as yeasts other than C. glabrata (sensitivity and specificity, 100%). The same isolates from SDA tested for RAT produced six false negatives and no false positives (sensitivity, 81%; specificity, 100%). The results show that CAC can be used as the sole primary medium for recovery of yeasts from clinical specimens. Additionally, isolates grown on CAC yield excellent results with the RAT test utilized in this study.


Subject(s)
Candida/growth & development , Culture Media , Trehalose/metabolism , Candida/isolation & purification , Candida/metabolism , Humans
12.
J Infect Dis ; 187(1): 77-86, 2003 Jan 01.
Article in English | MEDLINE | ID: mdl-12508149

ABSTRACT

A comprehensive analysis of Staphylococcus aureus superantigen (SAG) genes was undertaken in isolates from a major hospital and compared with isolates from patients with toxic shock syndrome (TSS). Polymerase chain reaction (PCR) analysis included recently discovered SAGs. Staphylococcal enterotoxin (SE) G and SEI were uniquely expressed in genital isolates. Genital isolates were similar to TSS isolates, although the latter frequently expressed TSS toxin 1. Both had a high frequency of SEG/SEI and a high number of SAG genes per bacterium. Detection of an SAG gene by PCR correlated with positive results in functional assays for SAG activity. Levels of serum antibodies to SEG and SEI, but not to other superantigens, were higher in healthy women than in men and served as an independent measure of the higher frequency of exposure to SEG/SEI among women. Together, the data suggest a role for SEG/SEI or closely linked genes in the adaptation of S. aureus to the genital mucosa environment.


Subject(s)
Enterotoxins/genetics , Staphylococcus aureus/immunology , Superantigens/genetics , Adolescent , Adult , Female , Humans , Male , Middle Aged , Mucous Membrane/microbiology , Polymerase Chain Reaction , Shock, Septic/microbiology , Staphylococcus aureus/genetics , Staphylococcus aureus/pathogenicity , Vagina/microbiology
13.
Antimicrob Agents Chemother ; 46(10): 3268-72, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12234857

ABSTRACT

Since the 1990s, the substantial increase in the rate of Candida glabrata infections has become a serious problem. As most C. glabrata infections arise from the host's endogenous microflora, the present prospective, multicenter analysis included all clinical isolates associated with colonization and with systemic and hematogenous candidiasis. Among 347 C. glabrata isolates, the overall rates of resistance to fluconazole (MIC > or = 64 micro g/ml) and itraconazole (MIC > or = 1 micro g/ml) were 10.7 and 15.2%, respectively, although for half (n = 148) of the itraconazole-susceptible isolates the MICs (0.25 to 0.5 micro g/ml) were in the susceptible-dependent upon dose range. Fluconazole resistance was more common among C. glabrata isolates obtained from centers caring for patients with cancer (MICs at which 90% of isolates are inhibited [MIC(90)s] = 32 micro g/ml) or AIDS (MIC(90)s > 64 micro g/ml) than among C. glabrata isolates from a community-based university medical center (MIC(90)s = 16 micro g/ml) (P = 0.001). Thirty-three bloodstream isolates and those obtained from other body sites had similar in vitro susceptibility profiles. The fluconazole MIC(90)s (< or =16 micro g/ml) for C. glabrata yeast isolates from the gastrointestinal tract were lower than those (> or =64 micro g/ml) for C. glabrata isolates from respiratory and urinary tract samples (P = 0.01). A similar discrepancy for itraconazole was not significant (P > 0.5). We did not observe differences in fluconazole or itraconazole susceptibility profiles among C. glabrata isolates associated with either hematogenous dissemination or colonization. The significant discrepancy in antifungal susceptibility among C. glabrata organisms isolated from hospitals in the same geographic region emphasizes the significance of periodic susceptibility surveillance programs for individual institutions, especially those providing care to patients at risk.


Subject(s)
Antifungal Agents/pharmacology , Candida glabrata/drug effects , Candidiasis/epidemiology , Fluconazole/pharmacology , Fungemia/epidemiology , Itraconazole/pharmacology , Candida glabrata/isolation & purification , Candidiasis/microbiology , Drug Resistance, Fungal , Fungemia/microbiology , Hospitals, Teaching , Hospitals, Urban , Humans , Microbial Sensitivity Tests , New York City , Prospective Studies , Sentinel Surveillance
14.
Scand J Infect Dis ; 34(2): 140-1, 2002.
Article in English | MEDLINE | ID: mdl-11928850

ABSTRACT

Fungal prosthetic valve endocarditis (PVE) is a serious complication of valve replacement surgery. We report the first case of documented Pichia ohmeri PVE in an immunocompetent man who was successfully treated with valve replacement and antifungal therapy with amphotericin B.


Subject(s)
Heart Valve Prosthesis/microbiology , Mitral Valve/microbiology , Mitral Valve/surgery , Mycoses/microbiology , Mycoses/therapy , Pichia/isolation & purification , Prosthesis-Related Infections/microbiology , Aged , Antifungal Agents/therapeutic use , Fluconazole/therapeutic use , Humans , Male , Mycoses/drug therapy , Mycoses/surgery , Pichia/classification , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/surgery , Prosthesis-Related Infections/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...